Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 31 Show results per page	View Search Criteria \| Help With Results

Last Modified: 10/24/2008 First Published: 6/23/2003


1.		Phase III Randomized Study of Doxorubicin, Cisplatin, Paclitaxel, and Filgrastim (G-CSF) Versus Carboplatin and Paclitaxel in Patients With Stage III or IV or Recurrent Endometrial Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				GOG-0209 GOG-0209, NCT00063999


2.		Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Not specified				Other				GYN03-0177 NCT00506779

Last Modified: 7/13/2007 First Published: 1/1/1998


3.		Phase II Study of Whole Body Hyperthermia Combined With Doxorubicin HCl Liposome and Fluorouracil in Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				UTHSC-MS-96205 NCI-V97-1356, NCT00003135

Last Modified: 5/28/2008 First Published: 11/18/2005


4.		Phase II Study of Induction Chemotherapy Comprising Carboplatin and Docetaxel Followed by Radiotherapy and Consolidation Chemotherapy Comprising Carboplatin and Docetaxel in Patients With Stage III or IV or Recurrent Endometrial Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				UMN-2004LS021 UMN-WCC-38, NCT00258362


5.		Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				No age specified				Other				HSC-MS-01-111 HSC-MS-01-111, NCT00178802


6.		Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				06US03IMP-852A [Cooley] MT2006-02, NCT00319748

Last Modified: 1/8/2008 First Published: 5/21/2007


7.		Phase II Study of Sunitinib Malate in Patients With Recurrent or Metastatic Endometrial Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				PMH-PHL-062 7713, PHL-062, NCT00478426


8.		Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Not specified				Other				2006-0211 NCT00392769


9.		Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Not specified				Other				2003-0823 NCT00388154

Last Modified: 5/22/2008 First Published: 5/4/2007


10.		Phase II Pilot Study of Irradiated Allogeneic Related Donor Lymphocyte Infusion in Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Any age				NCI				CINJ-3330 NCT00161187

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute